Explore
Trendline
Puma Biotechnology Raises 2026 Revenue Guidance Amid NERLYNX Demand
Puma Biotechnology Raises 2026 Revenue Guidance Amid NERLYNX Demand
Read More
Trendline
Verastem Oncology Reports Financial Results and Initiates New Cancer Trials
Verastem Oncology Reports Financial Results and Initiates New Cancer Trials
Read More
Trendline
Zai Lab Reports Q1 2026 Financial Results and Advances Oncology Pipeline
Zai Lab Reports Q1 2026 Financial Results and Advances Oncology Pipeline
Read More
Trendline
Silence Therapeutics Reports Q1 2026 Financial Results and Advances siRNA Therapies
Silence Therapeutics Reports Q1 2026 Financial Results and Advances siRNA Therapies
Read More
Trendline
BioLife Solutions Reports 25% Revenue Increase in Q1 2026, Strengthening Market Position
BioLife Solutions Reports 25% Revenue Increase in Q1 2026, Strengthening Market Position
Read More
Trendline
Janux Therapeutics Reports Q1 2026 Financial Results and Strategic Developments
Janux Therapeutics Reports Q1 2026 Financial Results and Strategic Developments
Read More
Trendline
Amylyx Pharmaceuticals Reports Q1 2026 Financial Results, Advances Clinical Trials
Amylyx Pharmaceuticals Reports Q1 2026 Financial Results, Advances Clinical Trials
Read More
Trendline
Rocket Pharmaceuticals Reports Financial Results and Progress in Gene Therapy Pipeline
Rocket Pharmaceuticals Reports Financial Results and Progress in Gene Therapy Pipeline
Read More
Trendline
Rocket Pharmaceuticals Reports Financial Results and Advances Gene Therapy Pipeline
Rocket Pharmaceuticals Reports Financial Results and Advances Gene Therapy Pipeline
Read More
Trendline
Delcath Systems Reports Increased Revenue and Strategic Developments in Q1 2026
Delcath Systems Reports Increased Revenue and Strategic Developments in Q1 2026
Read More
Trendline
Personalis Secures Medicare Coverage for Lung Cancer, Reports Q1 Financial Results
Personalis Secures Medicare Coverage for Lung Cancer, Reports Q1 Financial Results
Read More
Trendline
Soligenix Reports Financial Results and Strategic Updates Amid Clinical Trial Challenges
Soligenix Reports Financial Results and Strategic Updates Amid Clinical Trial Challenges
Read More
